Dermoscopic Findings of Small Plaque Parapsoriasis and Patch Stage Mycosis Fungoides and Histopathological Correlation

NCT ID: NCT05433727

Last Updated: 2022-06-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

60 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-02-14

Study Completion Date

2022-06-14

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Dermoscopic findings of small plaque parapsoriasis and patch stage mycosis fungoides (MF),histopathological correlation of the dermoscopic findings, and using these findings to differentiate two diseases by demonstrating the difference in diagnostic success of dermatologists

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Limited number of studies have been conducted on the dermoscopic findings of mycosis fungoides (MF) and small plaque parapsoriasis for the differentiation of these two diseases. Therefore, prospective studies involving a large number of patients and which can reach high magnification levels with videodermoscopy are needed to determine the criteria for discrimination. In our study, dermoscopic demonstration of vascularity will be achieved through videodermoscopy and capillaroscopy from the lesional skin, resulting in high magnification levels (x200).

In terms of histopathology and dermoscopy correlation, skin punch biopsy will be taken for diagnostic purposes. Videodermoscopy and lesional capillaroscopy will be performed to the same site of the lesion where punch biopsy will be taken. As a result patients who had the diagnosis of mycosis fungoides or parapsoriasis will be included to our study. After histopathological features are evaluated by pathologists, dermoscopic correlations will be examined for each lesion.

30 patients with clinical and histopathological diagnosis of mycosis fungoides, and 30 patients with clinical and histopathological diagnosis of small plaque parapsoriasis, who applied to the dermatology clinic of our hospital between february 2022 and june 2022 are included in the study. Patients did not use systemic treatment for 4 weeks and topical treatments in the last 2 weeks were included to the study.

Patient's demographical data, clinical data, videodermoscopy findings such as vascular structure (vascularity (shape, clustered, uniform, non-clustered) presence of scale ( diffuse or in patches or grooves, etc.), orange structural areas or specific clues will be evaluated. If vascularity is detected at x200 magnification in patients undergoing lesional capillaroscopy, characterization of vascularity (point, clustered, uniform, etc.) will be made.

After dermoscopic criteria are determined, the individuals whose dermatology education range from 1 to 15 years will be randomized and divided into two groups, and the correct diagnosis rates will be measured, with one group only clinical and the other group clinical and dermoscopy images together.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Mycosis Fungoides of Skin

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

mycosis fungoides, parapsoriasis, videodermoscopy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Mycosis fungoides group

Patients who routinely have punch skin biopsy for diagnostic purposes and who were both clinically and histopathologically diagnosed with mycosis fungoides will be included. Patients who only have mycosis fungoides patch lesion on their body, over the age of 18, and who have not received topical treatment for the last 2 weeks or systemic therapy for 4 weeks will be included. Demographic, clinical, videodermoscopy, capillaroscopy (lesional) and histopathological data will be recorded.

videodermoscopy, lesional capillaroscopy

Intervention Type DIAGNOSTIC_TEST

videodermoscopy and lesional capillaroscopy will be performed under different magnification levels to the skin lesions and data will be recorded.

Parapsoriasis group

Patients who routinely have punch skin biopsy for diagnostic purposes and who were both clinically and histopathologically diagnosed with parapsoriasis will be included. Patients who only have parapsoriasis patch lesion on their body, over the age of 18, and who have not received topical treatment for the last 2 weeks or systemic therapy for 4 weeks will be included. Demographic, clinical, videodermoscopy,capillaroscopy (lesional) and histopathological data will be recorded.

videodermoscopy, lesional capillaroscopy

Intervention Type DIAGNOSTIC_TEST

videodermoscopy and lesional capillaroscopy will be performed under different magnification levels to the skin lesions and data will be recorded.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

videodermoscopy, lesional capillaroscopy

videodermoscopy and lesional capillaroscopy will be performed under different magnification levels to the skin lesions and data will be recorded.

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient who have clinical/histopathological diagnosis of mycosis fungoides or parapsoriasis
* over the age of 18
* who have not received topical treatment for the last 2 weeks or systemic therapy for 4 weeks.
* patient who have patch lesions on their body

Exclusion Criteria

* Patient who do not have clinical/histopathological diagnosis of mycosis fungoides or parapsoriasis
* under the age of 18
* who have received topical treatment for the last 2 weeks or systemic therapy for 4 weeks.
* patient who does not have patch lesions on their body
Minimum Eligible Age

18 Years

Maximum Eligible Age

100 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Istanbul Training and Research Hospital

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Dilara İlhan Erdil

medical doctor (resident)

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ayse Esra Koku Aksu, MD

Role: STUDY_CHAIR

Istanbul Teaching and Research Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Istanbul Teaching and Research Hospital

Istanbul, Istanbul/Fatih, Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

References

Explore related publications, articles, or registry entries linked to this study.

Lallas A, Apalla Z, Lefaki I, Tzellos T, Karatolias A, Sotiriou E, Lazaridou E, Ioannides D, Zalaudek I, Argenziano G. Dermoscopy of early stage mycosis fungoides. J Eur Acad Dermatol Venereol. 2013 May;27(5):617-21. doi: 10.1111/j.1468-3083.2012.04499.x. Epub 2012 Mar 9.

Reference Type BACKGROUND
PMID: 22404051 (View on PubMed)

Xu C, Liu J, Wang T, Luo Y, Liu Y. Dermoscopic patterns of early-stage mycosis fungoides in a Chinese population. Clin Exp Dermatol. 2019 Mar;44(2):169-175. doi: 10.1111/ced.13680. Epub 2018 Jun 6.

Reference Type BACKGROUND
PMID: 29876963 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

11.02.2022 karar no:48

Identifier Type: -

Identifier Source: org_study_id